IgA肾病患者循环IgA1免疫复合物的蛋白质组学分析
本研究开发了一种新的蛋白质组学流程,通过凝集素亲和层析和尺寸排阻色谱从IgA肾病(IgAN)患者和健康对照血清中分离含IgA1的免疫复合物(IgA1-IC),再用液相色谱-质谱联用(LC-MS)分析。结果发现,与健康对照和其他未复合的IgA1分子形式相比,IgAN患者IgA1-IC色谱组分中有22种蛋白质丰度更高,包括免疫球蛋白、多种补体蛋白(含调节功能蛋白)和载脂蛋白;补体蛋白提示替代途径和凝集素途径参与,而非经典途径。
要点
- IgAN患者循环IgA1-IC中22种蛋白丰度高于健康对照及未复合IgA1。
- 差异蛋白包括免疫球蛋白、补体蛋白(含调节蛋白)和载脂蛋白。
- 补体蛋白提示替代途径和凝集素途径参与IgA1-IC,而非经典途径。
核心结论
- 新蛋白质组学流程能更好表征IgAN患者血清IgA1-IC,识别出包括补体成分和载脂蛋白在内的丰度升高蛋白。
- IgA1-IC中补体蛋白提示替代途径和凝集素途径参与,而非经典途径。
研究设计与样本
- 研究纳入IgAN患者和健康对照(HCs),从其血清中分离IgA1-IC。
- 采用凝集素亲和层析后接尺寸排阻色谱(SEC)分离IgA1-IC。
- 用酶联免疫吸附试验和SDS-PAGE评估IgA1产量和分子完整性。
- 经蛋白酶消化后用液相色谱-质谱联用(LC-MS)分析,并用非标定量(LFQ)比较IgAN患者与HCs及单体IgA1(mIgA1)和多聚IgA1(pIgA1)蛋白质组。
主要发现
- 与HCs类似组分及其他未复合IgA1分子形式相比,IgAN患者IgA1-IC色谱组分中有22种蛋白质丰度更高。
- 这些蛋白涵盖免疫球蛋白、多种补体蛋白(包括具有调节功能的补体蛋白)和载脂蛋白。
- identified proteins were validated by use of orthogonal serum preparation and analysis of previously published proteomics data.
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: IgA1-containing immune complexes (IgA1-IC) consisting of galactose-deficient IgA1 (Gal-deficient IgA1) and IgG autoantibodies are central to the pathogenesis of IgA nephropathy (IgAN). These IgA1-IC form in circulation, and additional proteins may be added before the deposition in the glomeruli. However, the composition of these circulating IgA1-IC is not fully understood. To address this gap in knowledge, we developed a novel proteomic workflow. METHODS: IgA1-IC from sera of patients with IgAN and healthy controls (HCs) were isolated by lectin-affinity chromatography followed by size-exclusion chromatography (SEC). IgA1 yield and molecular integrity were assessed by enzyme-linked immunosorbent assay and sodium dodecyl sulfate-polyacrylamide gel electrophoresis. After proteolytic digestion, IgA1-IC samples were analyzed by using liquid chromatography-mass spectrometry (LC-MS). LC-MS results were analyzed by label-free quantification (LFQ) to identify proteins in IgA1-IC of patients with IgAN versus HCs versus proteomes of monomeric IgA1 (mIgA1) and polymeric IgA1 (pIgA1). RESULTS: We ascertained that 22 proteins were more abundant in the chromatographic fractions with IgA1-IC from patients with IgAN compared with similar fractions from HCs and other, uncomplexed IgA1 molecular forms. These proteins encompassed immunoglobulins, several complement proteins, including those with regulatory functions, and apolipoproteins. In addition, the identified proteins were validated by use of orthogonal serum preparation and analysis of previously published proteomics data. CONCLUSION: Our new workflow better characterized the serum IgA1-IC of patients with IgAN by identifying proteins with elevated abundance in IgA1-IC in patients with IgAN, including complement components and apolipoproteins. Complement proteins identified in this study indicate that the alternative and lectin pathways are involved, but not the classical pathway.
引用
- Cunningham MA, Hargett AA, Holloway AK, et al. Proteomic Analysis of Circulating IgA1-Containing Immune Complexes in Patients with IgA Nephropathy. Kidney Int Rep. 2025. PMID: 41141540. doi:10.1016/j.ekir.2025.07.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。